The mother of a six-year-old girl with cancer has accused health chiefs of ‘putting a price’ on her daughter’s life.

Madison Allan’s consultant at Manchester Children’s Hospital has recommended she undergo a procedure called MIGB to shrink a tumour wrapped around her internal organs.

But a bid for funding from NHS Blackburn with Darwen Teaching Care Trust Plus to pay for new treatment at a cost of around £30,000 has been refused.

Now the regional board of NHS North West is being asked to approve the funding as a special case instead.

On Wednesday the board deferred the decision for a week.

Madison’s consultant at Manchester Children’s Hospital Dr Guy Makin had said the procedure would benefit the brave battler.

It is a new type of cancer treatment where radioactive iodine is injected directly into the tumour to kill off the cells.

Mum Samantha Allan said: “I am shocked and disgusted at the decision of the Care Trust Plus.

“They sent our consultant a letter saying they would not fund Madison’s treatment.

"He told us that it is the first time he has ever known the NHS to refuse like this.

“We’ve already got to go out of the country to get her treatment. This is sentencing her to death.

“A year ago Madison was given two months to live.

"Twelve months on and she’s still fighting, the treatment she’s having is working and she’s in a better place.

“This is one more way we have to try to get rid of the cancer.

"But if we don’t succeed we could be hearing those same words again.

“There’s a lot of talk in the care industry about cutbacks, well unfortunately it seems that is the price of my daughter’s life.”

MIGB is an abbreviation of metaiodobenzylguanidine and is used to directly eradicate tumour cells, rather than chemotherapy which kills both cancer and healthy cells.

Madison has a ‘spaghetti-like’ tumour wrapped around her internal organs, including her stomach and liver.

She is due to fly out to Germany later this year for scans to see if it has shrunk following pioneering treatment in the country paid for through a massive fundraising campaign.

Sam said: “We were supposed to hear on Wednesday, but couldn’t get hold of anyone to tell us until late on Thursday.

“They’ve now delayed the decision for a week while they get more information.

"It doesn’t make sense to me because if there’s not enough information, how have our local PCT come to their decision?

“It’s very, very frustrating and also worrying. At the moment Madison is not undergoing any treatment and is still getting pains.

“A week is a long time for someone in her position - anything could happen - the tumour could be growing now.

“How can our local care trust make this decision? They don’t see the child, just the paperwork.”

In November 2009, NHS doctors told Madison’s family there was nothing more they could do to help her after a 12-hour operation to remove the tumour was aborted because she was losing too much blood.

As the tumour grew, pressing on her stomach, liver, and damaging one of her kidneys, she slowly lost interest in food and had to be fed through a line in her nose.

Her family decided that the only chance was to pay for her to have high-tech treatment not currently available in the UK.

They set about trying to raise £250,000 to send her to Germany.

As she began chemotherapy at Manchester Children’s Hospital in preparation for a possible operation, her pain increased, and she had to be given 5ml of morphine intravenously every hour to dull the pain, but still this did not work.

Sensing time was of the essence, the local community threw all their efforts into raising money for the Madison Allan Appeal, to pay for the last-chance treatment.

In August last year Madison, still only five-years-old, jetted off to a hospital in Greifswald on the Baltic Coast in Germany for the trial treatment.

Since then the tumour has reduced in size by 2cms and the latest scans show that around 80 per cent is beginning to die off.

A spokesman for the NHS said: “The Blackburn with Darwen Teaching Care Trust Plus has received an application for MIBG and we are currently going through the appropriate steps in processing it.

"We are not able to discuss individual cases as a patient’s care is confidential.”